P3 Health Partners Q3 2026 Results $90M-$110M Guidance
P3 Health Partners reported Q3 2026 revenue of $396M and adjusted EBITDA of $21M, raising full-year guidance to $90M-$110M. At-risk membership decreased 9% year-over-year.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed